Stephen T. Gately
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Protease and Inhibitor Mechanisms
- Cancer, Lipids, and Metabolism
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
Papers in
-
- Protease and Inhibitor Mechanisms 7
- Cancer, Hypoxia, and Metabolism 5
-
- Angiogenesis and VEGF in Cancer 14
- Fibroblast Growth Factor Research 4
- Co-authors
- Gerald A. Soff (12 shared papers)William W. Li (1 shared paper)Steven S. Brem (12 shared papers)Robert West (1 shared paper)Ana Maria Crous Tsanaclis (5 shared papers)M. Sharon Stack (6 shared papers)Helena J. Mauceri (3 shared papers)Donald W. Kufe (3 shared papers)
- Journals
- Neurosurgery (4 papers)Cancer (3 papers)Journal of Clinical Investigation (2 papers)Biochemical Journal (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesCanadaBrazil
In The Last Decade
Stephen T. Gately
38 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 117
- Cancer Research 1.1k
- Immunology and Allergy 302
- Pharmacology 505
- Molecular Biology 1.9k
- Oncology 611
Countries citing papers authored by Stephen T. Gately
This map shows the geographic impact of Stephen T. Gately's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen T. Gately with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen T. Gately more than expected).
Fields of papers citing papers by Stephen T. Gately
This network shows the impact of papers produced by Stephen T. Gately. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen T. Gately. The network helps show where Stephen T. Gately may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen T. Gately, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 606 | |
| 2 | 2004 | 356 | |
| 3 | 2000 | 327 | |
| 4 | 1997 | 258 | |
| 5 | Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor. | 1990 | 211 |
| 6 | Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. | 1996 | 179 |
| 7 | Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. | 1998 | 177 |
| 8 | 2007 | 169 | |
| 9 | 1995 | 148 | |
| 10 | 2011 | 147 | |
| 11 | Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. | 1994 | 121 |
| 12 | 1997 | 106 | |
| 13 | 2003 | 106 | |
| 14 | 1999 | 101 | |
| 15 | Antiangiogenic scheduling of lower dose cancer chemotherapy. | 2002 | 99 |
| 16 | 1992 | 95 | |
| 17 | 2014 | 94 | |
| 18 | Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo. | 1997 | 83 |
| 19 | 1999 | 41 | |
| 20 | 1994 | 38 |
About Stephen T. Gately
Stephen T. Gately is a scholar working on Cancer Research, Molecular Biology, Pharmacology, Immunology and Allergy and Oncology, having authored 38 papers that have together received 3.7k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (14 papers), Protease and Inhibitor Mechanisms (7 papers), Inflammatory mediators and NSAID effects (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Fibroblast Growth Factor Research (4 papers), Estrogen and related hormone effects (3 papers), Cell Adhesion Molecules Research (3 papers) and Cancer, Stress, Anesthesia, and Immune Response (2 papers). The work is most often cited by research in Cancer Research (1.1k citations), Immunology and Allergy (302 citations), Pharmacology (505 citations), Molecular Biology (1.9k citations) and Oncology (611 citations). Stephen T. Gately has collaborated with scholars based in United States, Canada and Brazil. Frequent co-authors include Gerald A. Soff, William W. Li, Steven S. Brem, Robert West, Ana Maria Crous Tsanaclis, M. Sharon Stack, Helena J. Mauceri, Donald W. Kufe, Michael A. Beckett and Jan J. Enghild. Their work appears in journals such as Neurosurgery, Cancer, Journal of Clinical Investigation, Biochemical Journal and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.